Objective To investigate the impact of gestational age (GA) at diagnosis of fetal growth restriction (FGR) on obstetric management and rates of live birth and survival for very preterm infants with early-onset FGR.
Introduction
Decisions to initiate active management have a strong effect on survival for extremely preterm births and contribute to differences in survival rates between countries and hospitals. 1, 2 There is a large body of research on this topic, but most studies focus on survival and neonatal morbidities after live birth, without consideration of fetal deaths. 3, 4 These studies find that the thresholds for active management vary between 22 and 25 weeks of gestation across hospitals and countries. However, these studies include all very preterm births and it is unknown whether their conclusions apply to births with early-onset fetal growth restriction (FGR).
Fetal growth restriction is one of the principal causes of medically indicated very preterm birth. However, management of pregnancies diagnosed with early-onset FGR is complex and not standardised. Medical decisions are particularly difficult because FGR is associated with higher risks of mortality and morbidity 5, 6 and delivery is often indicated. 7 Evidence on the optimal timing of delivery remains unclear, despite one randomised trial, 8 and medical teams need to balance the negative effects of poor intrauterine growth with those of extreme prematurity.
To describe management decisions and outcomes for these births, information is needed on the moment at which FGR was diagnosed by the obstetrics team. Only a few studies have, however, investigated the effects of gestational age at the time of diagnosis on short-term and longterm outcomes, 9, 10 probably because this information is rarely collected. This study therefore aimed to investigate obstetric management and perinatal outcomes according to the gestational age at diagnosis of FGR using a French population-based cohort of very preterm births. We hypothesised that gestational age at diagnosis of FGR would play a key role in medical decisions and affect rates of live birth and survival.
Methods

Study design
Data came from the EPIPAGE 2 study, a population-based cohort study of very preterm births in France in 2011. 11 All live births, stillbirths and terminations of pregnancy (TOP) between 22 and 31 completed weeks of gestation were included in 25 French regions. The recruitment periods were different according to gestational age (GA) at birth: 8 months for births between 22 and 26 weeks and 6 months for those between 27 and 31 weeks to have a sufficient sample size for the most premature births, which occur less frequently. Perinatal data were abstracted from medical records in 447 maternity units and 309 neonatal units. Overall, 6555 births between 22 and 31 weeks GA were included in the cohort after parental consent.
11
Study population
The study population included singleton infants without severe congenital anomalies delivered between 22 and 31 weeks of gestation and diagnosed with FGR at or below 27 weeks of gestation. We selected the threshold of 27 weeks because after this time, active management for fetal indications is the norm. 1 We excluded multiple births because the growth rate and the management of these pregnancies differ from singleton pregnancies (n = 1546). 12 We also excluded severe congenital anomalies because of the poor prognosis unrelated to growth. 13 The majority of major congenital anomalies were known before birth, leading in most cases to terminations of pregnancy (n = 1219); however, a few were diagnosed at birth and they were also excluded (n = 132). Of 3698 singleton nonmalformed infants, 2989 were not diagnosed with FGR, 45 had missing data on diagnosis and 319 were diagnosed with FGR at ≥28 weeks. Our final sample therefore included 436 singleton infants with a diagnosis of FGR at ≤27 weeks of gestation (see study flow chart in the Supporting information, Figure S1 ).
Definitions and variables
Antenatal diagnosis of FGR Antenatal diagnosis of FGR was defined as the mention in medical charts of a growth-restricted fetus and at least one of the following criteria: an estimated fetal weight or an abdominal circumference less than the tenth centile, fetal Doppler abnormalities (reduced, absent or reversed umbilical end-diastolic flow Doppler based on the assessment of the medical team using either pulsatility index or resistance index; or increased middle cerebral artery end-diastolic flow or cerebral distribution; or reduced, absent or reverse flow in the ductus venosus), growth arrest, vascular disorders (pre-eclampsia, eclampsia, gestational hypertension, HELLP syndrome [haemolysis, elevated liver enzymes and low platelet count] or chronic hypertension) or an indicated delivery or TOP for FGR.
Ultrasound parameters
Information on the GA at the time of the scan, Doppler findings and biometric parameters (estimated fetal weight, abdominal circumference, femur length and growth arrest) were collected from ultrasound reports. For cases with missing data on estimated fetal weight, we used Hadlock's formula when abdominal circumference and femur length were available.
14 Centiles were defined by the care providers' reference curves or by national French references when centiles were not recorded. 15 For some fetuses, we had measures of both estimated fetal weight and abdominal circumference, whereas for others, one or the other was available. We created a composite variable to assess whether at least one measure was less than the third or tenth centiles of references. In France, the estimated date of delivery is based on the date of the last menstrual period and the measurement of crown-rump length at the firsttrimester ultrasound. Quality standards have been developed by the French College of Fetal Ultrasound. 16 
Obstetric management
Obstetric management included administration of antenatal steroids, prelabour caesarean delivery and level of the delivery hospital. In France, level 1 units have no neonatal unit; level 2 units have neonatal nurseries, but do not provide care for very preterm infants; level 3 are maternity units with neonatal intensive care. 17 We distinguished between spontaneous and indicated deliveries, which we grouped using a hierarchical classification with priority given to maternal indications (including eclampsia, placental abruption, HELLP syndrome and pre-eclampsia) followed by fetal indications (including anomalies of fetal cardiotocography, antenatal diagnosis of FGR, Doppler abnormalities, pre-eclampsia with a fetal indication, suspicion of chorioamnionitis and preterm premature rupture of the membranes (PPROM) with no infection). PPROM was defined as a rupture 12 hours or more before onset of labour.
Perinatal outcomes
We studied TOP, stillbirth, live birth, survival to discharge home from the neonatal unit and survival to discharge without severe neonatal morbidity. Severe morbidity was defined by the presence of any of the following morbidities: 18 severe bronchopulmonary dysplasia defined as the need for ≥30% oxygen and/or mechanical ventilator support or continuous positive airway pressure at 36 weeks of gestation, 19 severe necrotising enterocolitis (Bell stages II and III), 20 severe retinopathy of prematurity requiring treatment, cystic periventricular leucomalacia (i.e. periventricular white matter echolucencies at ultrasonography) and/or grade III or IV intraventricular haemorrhage.
Maternal and neonatal characteristics
These included maternal age, parity, smoking during pregnancy, vascular conditions and PPROM. Neonatal characteristics were GA at birth, fetal gender, birthweight and birthweight centile for gestational age and sex. Because there is an interval of time needed to plan delivery after fetal death, but fetal growth stops at death, we subtracted 2 days from the gestational age at birth to calculate birthweight centiles for stillbirths. This correction is necessary to avoid overestimating growth restriction among stillbirths and has been used in other studies. 21, 22 We used intrauterine growth references adapted to the French population. 23 Centiles were not customised on maternal characteristics, as this is not recommended in France. 24 
Statistical analysis
We first described the maternal, pregnancy and neonatal characteristics of the study population. We then analysed obstetric management, pregnancy outcomes and survival to discharge overall and without severe neonatal morbidity according to the gestational age at which FGR was diagnosed. The interval between diagnosis and delivery was explored graphically by plotting GA at diagnosis with GA at birth separately for indicated live births, spontaneous live births and stillbirths or TOP. Relative risks and their 95% confidence intervals were estimated with Poisson regression to identify factors associated with live birth. We used multilevel models with maternity unit as the second level to take into consideration the hierarchical nature of our data (infants clustered in hospitals). Multivariable models included clinical factors hypothesised to affect both obstetric decisions and the outcome including maternal age, parity, smoking, vascular disorders, gestational age at diagnosis of FGR, estimated fetal weight and abdominal circumference centiles at the time of diagnosis for FGR, growth arrest and fetal sex. Doppler results were not included in the model because they were more often missing for stillbirths. We did not include management variables (antenatal steroids, in utero transfer) as, in many cases, these reflect the decision to initiate delivery (and therefore a live birth).
Analyses were weighted to account for the 9-week longer recruitment period for births at 22-26 weeks of gestation. Analyses were performed using STATA 13.0 software (StataCorp LP, College Station, TX, USA).
Results
Among 3698 singleton non-malformed infants born between 22 and 31 weeks of gestation from the EPIPAGE 2 cohort, 436 were diagnosed with FGR before 28 weeks (11.8%) (see Supporting information, Figure S1 ). FGR was diagnosed at 20 weeks of gestation for eight infants and they were included with those diagnosed with FGR at 21 weeks of gestation. Table 1 describes the maternal and neonatal characteristics of the sample. More than half of mothers were nulliparous and developed vascular disorders. The mean GA at diagnosis of growth restriction was 24.3 weeks with a mean estimated fetal weight of 552.8 g. Estimated fetal weight was less than the third and the tenth centile for 68.7% and 92.8% of fetuses diagnosed with FGR, respectively. These percentages were 50.8% and 82.6% for the abdominal circumference, respectively. An abnormal Doppler and arrested growth were observed for 61.3% and 51.6% of cases. The mean GA at delivery was 27.1 weeks and mean birthweight was 689.1 g (average centile 4.8). In total, 77.5% and 88.3% of infants with antenatal diagnosis of FGR had a birthweight less than the third and tenth centiles, respectively. Table 2 presents obstetric management, pregnancy and neonatal outcomes by gestational age at diagnosis of FGR. Overall, 84.6% of the very preterm infants were born in level 3 maternity units: this proportion was <75% when FGR was diagnosed before 25 weeks of gestation and >90% when diagnosis was at 25 weeks or more. Both rates of prelabour caesarean and administration of antenatal steroids were <50% for diagnosis before 25 weeks, 65% at 25 weeks and almost 90% at 26 weeks of gestation. When FGR was diagnosed before 24 weeks of gestation, TOP were carried out in about one-fifth of cases. The probability of live birth was <50% for diagnosis before 25 weeks, 66.0% at 25 weeks and 90% at 26 and 27 weeks, as illustrated in Figure 1 . Rates of survival increased with GA at diagnosis of FGR. However, these rates did not differ by GA at diagnosis if only live births were considered. Figure 2 displays the interval between diagnosis of FGR and delivery by GA at diagnosis for indicated live births, spontaneous live births and stillbirths or TOP. Most of the stillbirths and TOP before 26 weeks of gestation occurred in the weeks following diagnosis. Live births immediately after the diagnosis of FGR were rare before 25 weeks of gestation. Most live births (94.1%) occurred after prelabour caesarean, mainly for deliveries after 26 weeks of gestation.
For births at 25 weeks of gestation, the proportion of indicated live births for fetal reasons with an abnormal Doppler was very rare (2.6%), but more frequent starting at 26 weeks (22.4% at 26 weeks, 43.0% at 27 weeks and 37.9% at 28 weeks of gestation). More generally, indicated very preterm live births were rarely for fetal conditions before 26 weeks of gestation at delivery (2.5% at 24 weeks, 5.2% at 25 weeks) whereas after 26 weeks, deliveries for fetal conditions prevailed over maternal reasons (57% at 27 weeks). Figure S2 in the supporting information provides these data on indications by GA at delivery.
In a multilevel model and after adjustment on all covariates, a reduced probability of live birth was associated with a low GA at diagnosis (adjusted relative risk [aRR] 0.49; 0.34-0.70 for a diagnosis at 24 weeks compared with 27 weeks), an estimated fetal weight or an abdominal circumference less than the third centile (aRR 0.78; 0.63-0.98) and male sex (aRR 0.85; 0.75-0.97) ( Table 3 ). PPROM and smoking during pregnancy were positively associated with live birth. Other maternal factors and growth arrest were not related to the probability of live birth.
Discussion
Main findings
Pregnancies diagnosed with FGR at or below 27 weeks of gestation constituted over 10% of singleton nonanomalous very preterm births. About half of pregnancies diagnosed with FGR resulted in a TOP or stillbirth when diagnosis occurred before 26 weeks and indicated deliveries before this GA were primarily for maternal indications. In contrast, when diagnosis was at 26 or 27 weeks of gestation, the percentage of stillborn infants was <10%. Low GA at diagnosis, biometric parameters less than the third percentile and male sex reduced the probability of live birth.
Strengths and limitations
The principal strength of our study is its population-based design and inclusion of all births between 22 and 31 weeks of gestation, including TOP and stillbirths. Data were abstracted from medical charts following a common protocol ensuring high quality. Our definition of antenatal diagnosis of FGR was based on notes in medical charts and confirmed by ultrasound reports. We also had information on GA at diagnosis which has been available in only a few previous studies. 9, 25 This information was available in the TRUFFLE study, which is a prospective randomised trial that assessed outcomes for FGR fetuses according to standardised monitoring protocols. However, inclusions only started at 26 weeks of gestation. 9 Our study also has some limitations. The EPIPAGE 2 study focused primarily on deliveries between 22 and 31 weeks of gestation so our results apply solely to infants delivered before 32 weeks. However, we can assume that these cases are the most severe, as they reflect situations requiring very preterm delivery or FGR in conjunction with other complications leading to very preterm delivery. In this light, our estimates reflect a lower bound of survival. We used a 27-week cut-off to focus on active management decisions and this also ensured that all fetuses had at least 5 weeks of follow up after diagnosis.
Interpretation
The GA at diagnosis of FGR impacted the probability of live birth and survival, associated with more perinatal interventions including antenatal steroids and prelabour caesarean. The initiation of active care for infants with FGR was highly restricted before 25 weeks GA and ****Calculated only for live births (n = 276). *****Severe neonatal morbidity was defined as the presence of any of the following morbidities: severe bronchopulmonary dysplasia, severe necrotising enterocolitis, severe retinopathy of prematurity requiring treatment and grade III or IV intraventricular haemorrhage. Interval between diagnosis of FGR and birth (weeks) Gestational age at diagnosis of FGR (weeks GA)
Live births after prelabour caesarean Live births after spontaneous labour Stillbirths/TOP Figure 2 . Live births and stillbirths/TOP by mode of labour according to the interval between antenatal diagnosis of FGR and delivery, and GA at diagnosis of FGR.
somewhat restricted at 25 weeks GA, most probably due to concerns about the adverse impact of FGR on neonatal mortality and morbidities and the need to perform a caesarean. 26 This was also revealed by the use of TOP for 10-20% of pregnancies with FGR when diagnosis occurred before 25 weeks of gestation. Pregnancies complicated by FGR were an indication for TOP between 22 and 26 weeks of gestation in the EPICure 2 study in the UK, but data on the frequency of TOP for fetuses with early-onset FGR were not presented. 27 Compared with the TRUFFLE trial, our study reported slightly lower proportions of live births for fetuses diagnosed with FGR at 26 and 27 weeks of gestation (92% versus 95%). 9 We had a higher rate of overall mortality (i.e. fetal and neonatal deaths of 25% versus 17%) but the TRUFFLE trial monitored FGR fetuses according to standardised protocols in contrast with our observational design reflecting more heterogeneous medical practices.
Thresholds for active management of extremely preterm births are higher in France than many other countries, but are in-line with the general consensus for active management at 25 weeks GA documented by a review of international guidelines. 28 Recent studies from the USA, France and other European countries confirm that active management is the norm at 25 weeks, despite differences in practice before this time. [2] [3] [4] 29, 30 Our results suggest that the GA threshold for initiation of active care for births with early-onset FGR may be higher than for other extremely preterm births. Given the higher thresholds for active management in France, it would be of interest to include similar data on timing of diagnosis for growth-restricted infants in future studies from countries with more active approaches, such as Sweden or Japan.
Our results highlight the importance of the choice of the denominator when assessing active management and survival. We found that GA at diagnosis of FGR affected survival when fetal deaths were included, but not in analyses of live-born infants only. Decisions to initiate active care of infants with early-onset FGR are taken before delivery, as witnessed by the high percentages of live births by prelabour caesarean, and therefore the evaluation of obstetric management requires consideration of fetal deaths. Other research has also shown that the choice of denominator is highly relevant for assessing active management in extremely preterm infants and that reporting outcomes solely for live births overestimates survival. 31, 32 One study showed that survival rates were 34% between 23 and 25 weeks of gestation for live-born infants, but only 14% if stillbirths were included. 33 If selection occurs before delivery and is based on criteria associated with survival, this could confer a false survival advantage to live-born infants diagnosed with FGR. In our study, we analysed only short-term outcomes of very preterm infants diagnosed with FGR, but having data on long-term outcomes is necessary for assessing practices. In the TRUFFLE trial, neurodevelopmental outcomes at 2 years were not different regardless of the antenatal monitoring strategies, but results were not analysed according to GA at diagnosis of FGR. 10 We also identified other clinical factors associated with live birth. Management factors, such as antenatal steroids, were not considered because our focus was on the decision to initiate care. In addition to gestational age, however, prenatal fetal biometry less than the third percentile of norms had an impact on the probability of live birth. Male sex was also associated with a lower probability of live birth, as found elsewhere. 34 In contrast, PPROM and smoking during pregnancy were positively associated with live birth. PPROM may lead to spontaneous labour resulting in more live births. There is no clear explanation for the association with smoking. Better outcomes among FGR infants with mothers who smoke have been noted; 35 however, this research on term infants would seem to be less relevant for very preterm infants.
Conclusion
The GA at diagnosis of FGR affects the probability of live birth and survival for the 10% of very preterm singleton births with early-onset FGR. Future studies should include stillbirths and TOP for investigations of the management and prognosis of very preterm infants with early-onset FGR. More generally, the timing of diagnosis of FGR should be part of routine data collection on very preterm births.
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